Acknowledgement
Supported by : 전남대학교병원
References
- Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11: 150-5 https://doi.org/10.1016/0165-6147(90)90066-H
- Moreland RB, Goldstein II, Kim NN, Traish A: Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endoctinol Metab 1999; 10: 97-104 https://doi.org/10.1016/S1043-2760(98)00127-1
- Pyne NJ, Atshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-22 https://doi.org/10.1042/bst0241019
- Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12 https://doi.org/10.1056/NEJM199312303292706
- Nathan C: Inducible nitric oxide synthase: what diffetence does it make? J Clin Invest 1997; 100: 2417-23 https://doi.org/10.1172/JCI119782
- Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V: Sildenafil ptoduces antinockeption and increases morphine antinociception in the formalin test. Eur J Pharmacol 2000; 400: 81-7 https://doi.org/10.1016/S0014-2999(00)00361-7
- Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001; 909: 170-8 https://doi.org/10.1016/S0006-8993(01)02673-7
- Asomoza-Espinosa R, Alonso-Lopez R, Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Torres-Lopez JE, Granados-Soto V: Sildenafil incteases diclofenac antinociception in the formalin test. Eur J Pharmacol 2001; 418: 195-200 https://doi.org/10.1016/S0014-2999(01)00956-6
- Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil, a phospho-diestetase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology 2003; 67: 150-6 https://doi.org/10.1159/000067802
- Patil CS, Jain NK, Singh A, Kulkarm SK: Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception. Pharmacology 2003; 69: 183-9 https://doi.org/10.1159/000073662
-
Terrert NK, Bell AS, Brown D, Ellis P: Sildenafil (
$Vigra^{TM}$ ) a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction. Bioorg Med Chem Lett 1996; 6: 1819-24 https://doi.org/10.1016/0960-894X(96)00323-X - Boolell M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-61 https://doi.org/10.1046/j.1464-410X.1996.10220.x
- Yoon MH, Choi JI, Kwak SH: Characteristic of interactions berween intrathecal gabapentin and either clonidine or neostigmine in the formalin test. Anesth Analg 2004; 98: 1374-9
- Yoon MH, Yaksh TL: The effect of intrathecal gabapentin on pain behavior and hemodynamic on rhe formalin rest in the rat. Anesth Analg 1999; 89: 434-9 https://doi.org/10.1097/00000539-199908000-00034
- Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6 https://doi.org/10.1016/0031-9384(76)90029-9
- Tallarida RJ, Murray RB: Manual of pharmacologic calculations with computer programs. 2nd ed. New York, Springer-Verlag. 1987, pp 1-95
- Wilcox GL, Seybold V: Pharmacology of spinal afferent processing. In: Anesthesia: Biologic foundations. Edited by Yaksh TL, Lynch III C, Zapol WM, Maze M, Biebuyck JF, Saidman LJ: Philadelphia, Lippincott-Raven Publishers. 1997, pp 557-76
- Stacey P, Rulten S, Dapling A, Phillips SC: Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 1998; 247: 249-54 https://doi.org/10.1006/bbrc.1998.8769
- Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-22 https://doi.org/10.1042/bst0241019
- Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48 https://doi.org/10.1152/physrev.1995.75.4.725